Cargando…

Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study

BACKGROUND: Higher serum 25-hydroxyvitamin D [25(OH)D] concentrations have been associated with a lower risk of multiple cancer types across a range of 25(OH)D concentrations. OBJECTIVES: To investigate whether the previously reported inverse association between 25(OH)D and cancer risk could be repl...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDonnell, Sharon L., Baggerly, Carole, French, Christine B., Baggerly, Leo L., Garland, Cedric F., Gorham, Edward D., Lappe, Joan M., Heaney, Robert P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822815/ https://www.ncbi.nlm.nih.gov/pubmed/27049526 http://dx.doi.org/10.1371/journal.pone.0152441

Ejemplares similares

Correction: Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study
por: McDonnell, Sharon L., et al.
Publicado: (2018)

Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort
por: McDonnell, Sharon L., et al.
Publicado: (2018)

Maternal 25(OH)D concentrations ≥40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center
por: McDonnell, Sharon L., et al.
Publicado: (2017)

Letter to Veugelers, P.J. and Ekwaru, J.P., A Statistical Error in the Estimation of the Recommended Dietary Allowance for Vitamin D. Nutrients 2014, 6, 4472–4475; doi:10.3390/nu6104472
por: Heaney, Robert, et al.
Publicado: (2015)

A Novel Approach Localizes the Association of Vitamin D Status With Insulin Resistance to One Region of the 25-Hydroxyvitamin D Continuum(1)(2)
por: Heaney, Robert P., et al.
Publicado: (2013)

Sunlight and Vitamin D: Necessary for Public Health
por: Baggerly, Carole A., et al.
Publicado: (2015)

The likelihood of having serum level of PSA of ≥4.0 ng/mL and ≥10.0 ng/mL in non-obese and obese Nigerian men with LUTS
por: Adegun, Patrick Temi, et al.
Publicado: (2015)

Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths
por: Grant, William B., et al.
Publicado: (2020)

25-Hydroxyvitamin D variability within-person due to diurnal rhythm and illness: a case report
por: French, Christine B., et al.
Publicado: (2019)

Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL)
por: Chung, Jae Hoon, et al.
Publicado: (2020)

Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml
por: Su, Rui, et al.
Publicado: (2022)

Plasma 25-hydroxyvitamin D concentration and risk of type 2 diabetes and pre-diabetes: 12-year cohort study
por: Park, Sue K., et al.
Publicado: (2018)

Reply: “Vitamin D Supplementation in Influenza and COVID-19 Infections. Comment on: Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths Nutrients 2020, 12(4), 988”
por: Grant, William B., et al.
Publicado: (2020)

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
por: Maghbooli, Zhila, et al.
Publicado: (2020)

Clinical utility of serum folate measurement in tertiary care patients: Argument for revising reference range for serum folate from 3.0 ng/mL to 13.0 ng/mL
por: Singh, Gurmukh, et al.
Publicado: (2015)

Combining clinical parameters and multiparametric magnetic resonance imaging to stratify biopsy-naïve men for an optimum diagnostic strategy with prostate-specific antigen 4 ng ml(−1) to 10 ng ml(−1)
por: Zhang, Chi-Chen, et al.
Publicado: (2022)

Exploring parallel MPI fault tolerance mechanisms for phylogenetic inference with RAxML-NG
por: Hübner, Lukas, et al.
Publicado: (2021)

Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
Publicado: (2020)

Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?
por: Lee, Seung Hwan, et al.
Publicado: (2011)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
por: LIU, Xin, et al.
Publicado: (2015)

PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5–10.0 ng ml(-1) and 10.1–20.0 ng ml(-1): a multicenter study
por: Lin, Yu-Rong, et al.
Publicado: (2015)

Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
por: Hinev, Alexander I., et al.
Publicado: (2012)

Stromal Tumor of Uncertain Malignant Potential (STUMP) With PSA >500 ng/ml: A Case Report
por: Johnson, Michael H., et al.
Publicado: (2015)

The Chances of Subsequent Cancer Detection in Patients with a PSA > 20 ng/ml and an Initial Negative Biopsy
por: Shaida, Nadeem, et al.
Publicado: (2009)

Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis
por: Kan, Hung-Cheng, et al.
Publicado: (2017)

RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference
por: Kozlov, Alexey M, et al.
Publicado: (2019)

Adaptive RAxML-NG: Accelerating Phylogenetic Inference under Maximum Likelihood using Dataset Difficulty
por: Togkousidis, Anastasis, et al.
Publicado: (2023)

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0–10.0 ng/ml
por: Chen, Rui, et al.
Publicado: (2015)

Bias, Randomization, and Ovarian Proteomic Data: A Reply to “Producers and Consumers”
por: Baggerly, Keith A., et al.
Publicado: (2007)

Nomogram for Prediction of Prostate Cancer with Serum Prostate Specific Antigen Less than 10 ng/mL
por: Ahn, Jae Hyun, et al.
Publicado: (2014)

Correlation of Serum Androgens and Pituitary Hormone Levels with Serum PSA Less Than 2.5 NG/ML
por: Sofikerim, Mustafa, et al.
Publicado: (2007)

NgR1 and NgR3 are Receptors for Chondroitin Sulfate Proteoglycans
por: Dickendesher, Travis L., et al.
Publicado: (2012)

On the Proton-Bound Noble Gas Dimers (Ng-H-Ng)(+) and (Ng-H-Ng’)(+) (Ng, Ng’ = He-Xe): Relationships between Structure, Stability, and Bonding Character
por: Borocci, Stefano, et al.
Publicado: (2021)

Why randomized controlled trials of calcium and vitamin D sometimes fail
por: Lappe, Joan M., et al.
Publicado: (2012)

Surface Adjustment of Reverse Phase Protein Arrays using Positive Control Spots
por: Neeley, E. Shannon, et al.
Publicado: (2012)

The value of percentage free prostate specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria
por: Ezenwa, E.V., et al.
Publicado: (2012)

Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL
por: Iwamoto, Hiroaki, et al.
Publicado: (2019)

Development and validation of a nomogram for predicting prostate cancer in patients with PSA ≤ 20 ng/mL at initial biopsy
por: Wu, Qiang, et al.
Publicado: (2021)

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
por: Solomonidou, Nantia, et al.
Publicado: (2023)

Effect of Vitamin D(3) Supplementation vs. Dietary–Hygienic Measures on SARS-CoV-2 Infection Rates in Hospital Workers with 25-Hydroxyvitamin D3 [25(OH)D3] Levels ≥20 ng/mL
por: Romero-Ibarguengoitia, Maria Elena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r2lvh3hbshq2fiurcafg0fab70